The radioprotection of salivary glands by vitamin C and sodium bicarbonate in 131I treatment of patients with differentiated thyroid carcinoma

被引:0
作者
Tong, Huimin [1 ]
Gao, Ying [1 ]
Zhang, Xiaomin [1 ]
Li, Xiaoqian [1 ]
Luo, Liping [1 ]
Huang, Nan [1 ]
Hu, Tingting [1 ]
An, Jie [1 ]
Wang, Jin [1 ]
Cheng, Yan [1 ]
机构
[1] Shanxi Med Univ, First Hosp, Taiyuan, Peoples R China
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
1696
引用
收藏
页数:6
相关论文
共 50 条
[21]   Low activity treatment with 131I in differentiated thyroid cancer [J].
Olivan-Sasot, P. ;
Prado-Wohlwend, S. ;
Sanchez-Vano, R. ;
Yepes-Agudelo, A. ;
Agudelo-Cifuentes, M. ;
Bernal-Vergara, J. ;
Bello-Arques, P. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 :S608-S609
[22]   Incremental Value of 131I SPECT/CT in the Management of Patients with Differentiated Thyroid Carcinoma [J].
Chen, Libo ;
Luo, Quanyong ;
Shen, Yan ;
Yu, Yongli ;
Yuan, Zhibin ;
Lu, Hankui ;
Zhu, Ruisen .
JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (12) :1952-1957
[23]   131I SPECT/CT in the Follow-Up of Patients With Differentiated Thyroid Carcinoma [J].
Menges, Mareen ;
Uder, Michael ;
Kuwert, Torsten ;
Schmidt, Daniela .
CLINICAL NUCLEAR MEDICINE, 2012, 37 (06) :555-560
[24]   Implications of mediastinal uptake of 131I with regard to surgery in patients with differentiated thyroid carcinoma [J].
Haveman, JW ;
Phan, HTT ;
Links, TP ;
Jager, PL ;
Plukker, JTM .
CANCER, 2005, 103 (01) :59-67
[25]   Bone Marrow Function After 131I Therapy in Patients With Differentiated Thyroid Carcinoma [J].
Prinsen, Hester T. ;
Hesselink, Esther N. Klein ;
Brouwers, Adrienne H. ;
Plukker, John T. M. ;
Sluiter, Wim J. ;
van der Horst-Schrivers, Anouk N. A. ;
van Imhoff, Gustaaf W. ;
Links, Thera P. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (10) :3911-3917
[26]   Additional Value of 131I SPECT/CT in the Management of Patients with Differentiated Thyroid Carcinoma [J].
Marini, I. ;
Maussier, M. ;
Perotti, G. ;
Salvatori, M. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) :S72-S72
[27]   Interrupted 131I Procedures for Patients With Differentiated Thyroid Cancer [J].
Karls, Shawn ;
Abikhzer, Gad ;
Tamilia, Michael ;
Probst, Stephan .
CLINICAL NUCLEAR MEDICINE, 2017, 42 (04) :247-249
[28]   Evaluation of the Efficiency of 131I Ablative Dose of Residual Thyroid Tissue in Patients with Differentiated Thyroid Carcinoma [J].
Ben Sellem, D. ;
Kraiem, T. ;
Letaief, B. ;
Ben Slimene, M. F. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 :S348-S349
[29]   Usefulness of second 131I treatment in biochemical persistent differentiated thyroid cancer patients [J].
Gambale, Carla ;
Prete, Alessandro ;
Contartese, Lea ;
Torregrossa, Liborio ;
Bianchi, Francesca ;
Molinaro, Eleonora ;
Materazzi, Gabriele ;
Elisei, Rossella ;
Matrone, Antonio .
EUROPEAN THYROID JOURNAL, 2023, 12 (06)
[30]   Analysis of the incidence and influencing factors of hyponatremia before 131I treatment of differentiated thyroid carcinoma [J].
Jing-Jia Cao ;
Can-Hua Yun ;
Juan Xiao ;
Yong Liu ;
Wei Wei ;
Wei Zhang .
World Journal of Clinical Cases, 2021, (36) :11173-11182